Search
Search Constraints
You searched for: Is Part Of Progress in polymer science. Volume 44(2015:May)Limit your search
- 547.7 9
- Polymerization -- Periodicals 9
- Polymers -- Industrial applications -- Periodicals 9
- Polymers -- Periodicals 9
- Polymères -- Périodiques 9
- Polymérisation -- Périodiques 9
- ALG alginic acid -- AMPSNa 2-acrylamido-2-methylpropane sulfonic acid -- CL caprolactone -- CMC carboxymethylcellulose -- CNS central nervous system -- DDS drug delivery system -- DX dextran -- EBs embryoid bodies -- ECM extracellular matrix -- EG ethylene glycol -- EGF epidermal growth factor -- ES embryonic stem -- FDA Food and Drug Administration -- GAGs glycosaminoglycans -- HA hyaluronic acid -- HPMC hydroxypropylmethylcellulose -- ICAM-1 intercellular adhesion molecule-1 -- KGF keratinocyte growth factor -- LCST lower critical solution temperature -- MC methylcellulose -- NO nitric oxide -- NSAIDs nonsteroidal anti-inflammatory drugs -- PCLA poly(ɛ-caprolactone-co-lactide)b-PEG-b-poly(ɛ-caprolactone-co-lactide) -- PDMS poly(dimethyl siloxane) -- PE polyethylene -- PEG poly(ethylene glycol) -- PLA polylactic acid -- PMMA poly(methyl methacrylate) -- PNIPAAm poly(N-isopropylacrylamide) -- Poly(MEO2MA-co-OMEGA) poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo(ethylene glycol) methacrylate) -- PS polystyrene -- PTFE poly(tetrafluoroethylene) -- PU polyurethane -- PVA poly(vinyl alcohol) -- RBCs red blood cells -- semi-IPN semi-interpenetrating polymer network -- SEMs self-assembled monolayers -- TCPS tissue culture polystyrene -- VCAM-1 vascular cell adhesion molecule-1 2
- Biomaterials -- Cell anti-adhesion -- Bioinert surface -- Tissue anti-adhesion -- Tissue adhesion barrier 2
- 3D 3-dimensional -- ACPPD ACPPs conjugated dendrimers -- ACPPs activatable cell-penetrating peptides -- Ag DENPs dendrimer-entrapped Ag NPs -- Ag DSNPs dendrimer-stabilized Ag NPs -- Au DENPs dendrimer-entrapped Au NPs -- Au DSNPs dendrimer-stabilized Au NPs -- CT computed tomography -- DANPs dendrimer-assembled nanoparticles -- DENPs dendrimer-entrapped NPs -- DMAA-IPA 3-N-[(N', N'-dimethylaminoacetyl) amino]-α-ethyl-2, 4, 6-triiodo-benzenepropanoic acid -- DNCs dendrimer nanoclusters -- DOTA tetraazacyclododecane tetraacetic acid -- DPTA diethylenetriaminepentaacetic acid -- DSNPs dendrimer-stabilized NPs -- DTA diatrizoic acid -- EDC 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimidehydrochloride -- EPR enhanced permeability and retention -- FA folic acid -- FAR FA receptors -- FI fluorescein isothiocyanate -- G5.NH2 amine-terminated generation 5 PAMAM dendrimers -- HuTac humanized anti-Tac IgG -- mPEG PEG monomethyl ether -- MR magnetic resonance -- NCPs nanocomposite particles -- NIR near infrared -- NPs nanoparticles -- NSF nephrogenic systemic fibrosis -- OEG oligoethylene glycol -- PAMAM poly(amidoamine) -- PBS phosphate buffered saline -- PEG polyethylene glycol -- PET positron emission tomography -- PGA poly(glutamic acid) -- PLL poly(L-lysine) -- PPI poly(propylene imine) -- QDs quantum dots -- RGD arginine-glycine-aspartate -- SCIO shell-crosslinked iron oxide -- SCN-Bz-DTPA 2-(p-isothiocyanatobenzyl) diethylenetriaminepentaacetic acid -- SPECT single photon emission computed tomography 1
- AD Alzheimer's disease -- ALS amyotrophic lateral sclerosis -- BBB blood brain barrier -- DMAEMA 2-dimethylaminoethyl methacrylate -- HD Huntington's disease -- MPTP 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine -- MS multiple sclerosis -- 6-OHDA 6-hydroydopamine -- PAMAM poly(amido amide) -- PD Parkinson's disease -- PEG polyethylene glycol -- PEI polyethylene imine -- PLGA poly(lactic-co-glycolic acid) -- PLL poly-l-lysine -- SCI spinal cord injury 1